Lung cancer is the leading cause of cancer-related deaths worldwide. Long non-coding
RNAs (lncRNAs) have emerged as key regulators of cancer development and progression …

Since its initial involvement in numerous neurodegenerative pathologies in 2006, either as a
principal actor or as a cofactor, new pathologies implicating transactive response (TAR) …

Simple Summary The introduction of epidermal growth factor receptor (EGFR)-tyrosine
kinase inhibitors (TKIs) has revolutionized the treatment of lung cancer. Nevertheless, TKI …

Background Gastric cancer remains the leading cause of cancer death in the world. It is
increasingly evident that long non-coding RNAs (lncRNAs) transcribed from the genome …

Background Osteosarcoma (OS) is the most common primary malignant bone tumors in
children and adolescents. Large numbers of studies have focused on the long non-coding …

Lung cancer has the highest mortality and morbidity rates among all cancers worldwide.
Despite many complex treatment options, including radiotherapy, chemotherapy, targeted …

The Notch signaling pathway plays pivotal roles in cell proliferation, stemness and invasion
of non-small cell lung cancer (NSCLC). The human Notch family consists of four receptors …

Background. Immune checkpoint inhibitors (ICIs) have become a standard care in non‐small‐
cell lung cancer (NSCLC). However, its application to epidermal growth factor receptor …

Background: With the increasing number of new cancer cases and mortality rates, cancer
has become a serious global health problem, but there are no ideal cancer biomarkers for …

Noncoding ribonucleic acids (ncRNAs) have surfaced as essential orchestrators within the
intricate system of neoplastic biology. Specifically, the epidermal growth factor receptor …